Investment in Other Company (Details Narrative) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2020 |
Aug. 14, 2020 |
|
Stock issued during the period, shares | 2,164,502 | |
Pathnova Laboratories PTE Ltd [Member] | ||
Investments in pathnova | $ 224 | |
Stock issued during the period, shares | 461,538 | |
Percentage of sharehold | 4.38% | |
Pathnova Laboratories PTE Ltd [Member] | SGD [Member] | ||
Investments in pathnova | $ 300 | |
Subscription Agreement [Member] | Maximum [Member] | ||
Subscription of shares | 4,615,385 | |
Subscription Agreement [Member] | SGD [Member] | Maximum [Member] | ||
Investments in pathnova | $ 3,000 |
X | ||||||||||
- Definition Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Percent of net assets at close of period. For schedules of investments that are categorized, each category has a percent of net assets for the aggregated value of the Investments in the category. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|